Publication: Adjuvant or salvage radiotherapy in postoperative prostate cancer
dc.contributor.coauthor | Kuban, Deborah A. | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Bölükbaşı, Yasemin | |
dc.contributor.kuauthor | Selek, Uğur | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T22:58:34Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Prostate-specific antigen (PSA) screening increased the diagnosis of prostate cancer at a localized stage to be treated with a curative intent; approximately half of them undergo radical prostatectomy, and roughly one third of surgically treated patients are expected to experience a recurrence in 10 years' follow-up. Once PSA failure occurs, many develop distant metastases at a median of 8 years and afterward followed by cancer-related death at a median of 5 years. Biochemical failure risk after radical prostatectomy is mainly expected mostly in men with any of the following features: detectable postoperative PSA, positive surgical margins, extraprostatic extension of tumor (T3a), seminal vesicle invasion (T3b), and Gleason score ≥ 8. The radiotherapy in the undetectable PSA environment (<0.01 ng/mL) within 4 months after prostatectomy is termed as "adjuvant," while radiotherapy in rising PSA within any time after prostatectomy is defined as "salvage." | |
dc.description.indexedby | Scopus | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.identifier.doi | 10.1007/978-3-319-56114-1_17 | |
dc.identifier.isbn | 9783-3195-6114-1 | |
dc.identifier.isbn | 9783-3195-6113-4 | |
dc.identifier.scopus | 2-s2.0-85055910790 | |
dc.identifier.uri | https://doi.org/10.1007/978-3-319-56114-1_17 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/7745 | |
dc.language.iso | eng | |
dc.publisher | Springer | |
dc.relation.ispartof | Principles and Practice of Urooncology: Radiotherapy, Surgery and Systemic Therapy | |
dc.subject | Oncology | |
dc.subject | Urology | |
dc.subject | Nephrology | |
dc.title | Adjuvant or salvage radiotherapy in postoperative prostate cancer | |
dc.type | Book Chapter | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Selek, Uğur | |
local.contributor.kuauthor | Bölükbaşı, Yasemin | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |